Purchase Order 75F40124P00487

Award Date 9/23/24
Potential Completion Date 11/18/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Berwyn Heights, MD 20740, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Crystal Chem Inc. was awarded a $19,460 firm fixed price purchase order as the prime contractor to provide ELISA test kits to the Food and Drug Administration. The kits will support the FDA's ongoing work to detect allergens through laboratory analysis. As a woman-owned small business specializing in assay products for research, Crystal Chem will deliver the ELISA kits for allergen detection to the FDA's facility in Elk Grove Village, Illinois by September 2022. The purchase order was awarded by...
This federal contract award was made by the Department of Health and Human Services Food and Drug Administration (FDA) to Crystal Chem Inc., a woman-owned small business. The $19,460.00 firm-fixed-price purchase order is for the procurement of ELISA test kits manufactured by Crystal Chem Inc. to support the FDA's ongoing work on allergens detection. The contract was set aside for small businesses. Crystal Chem Inc. is a minority-owned, woman-owned small business that specializes in providing...
The Department of Health and Human Services awarded a firm fixed-price purchase order to Crystal Chem Inc., a woman-owned small business, for a Casein Protein ELISA Kit. The $11,240 contract, awarded on June 24, 2014, was placed with the Food and Drug Administration for the provision of these allergen detection kits. This award was not set aside for small businesses. Crystal Chem Inc. has previously received similar awards from the Department of Health and Human Services for ELISA kits to...
The Department of Health and Human Services' Food and Drug Administration awarded Radix Biosolutions LLC, a for-profit limited liability company specializing in assay development and bioanalytical services, a firm fixed-price purchase order to provide XMAP Food Allergen Detection Assay (XMAP FADA) kits. The $149,850.00 award has a completion date of November 30, 2023 and does not utilize a set-aside designation. The XMAP FADA kits will support the FDA's food safety inspection and sample analysis...
The Department of Health and Human Services' Food and Drug Administration awarded a firm fixed-price purchase order to Radix Biosolutions LLC, a manufacturer of goods, to provide XMAP Food Allergen Detection Assay Buffered-Detergent Protocol Kits. The $150,000.00 contract has a completion date of January 31, 2021. Radix Biosolutions LLC has provided similar allergen detection assay kits to the FDA through prior awards. This order supports the agency's food safety inspection and sample analysis...
The U.S. Food and Drug Administration (FDA) awarded a $235,200.00 firm fixed-price purchase order to Radix Biosolutions LLC, a for-profit limited liability company, for the delivery of 150 XMAP Assay Kits for Food Allergens. This award was not set aside for small businesses. Radix Biosolutions LLC is a specialized manufacturer of these critical laboratory diagnostic tools, which support the FDA's and U.S. Department of Agriculture's Food Safety and Inspection Service's (FSIS) food safety...
This firm fixed-price purchase order for $12,903.20 was awarded by the Department of Health and Human Services' Food and Drug Administration to Radix Biosolutions LLC. The contract calls for the delivery of XMAP Food Allergen Detection Assay Kits to the FDA Northeast Food and Feed Laboratory in Jamaica, New York. The solicitation sought these multi-allergen detection kits for use with the laboratory's existing xMAP-Magpix analyzer to improve the agency's sample analysis turnaround time and...
The U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research, awarded a Firm Fixed Price contract to Iggenix, Inc. to procure 3 grams of a human monoclonal antibody specific for a first epitope on the cat allergen Fel d 1, and 1 gram of a biotinylated human monoclonal antibody for a second distinct epitope on Fel d 1. These antibodies are intended for use in Enzyme Linked Immunosorbent Assay (ELISA) or ImmunoEnzymetric Assay (IEMA) applications. The contract,...
The U.S. Food and Drug Administration (FDA), an agency of the Department of Health and Human Services (HHS), has awarded a firm fixed-price purchase order valued at $25,749.97 to Agilent Technologies Inc. for a CFSAN-2023-118815-BNE-GC-MSMS flow modulator. The contract period of performance runs from July 19, 2023 through September 29, 2024. As the prime contractor, Agilent Technologies Inc. will deliver the specified flow modulator to the FDA's Center for Food Safety and Applied Nutrition...
The U.S. Department of Health and Human Services' Food and Drug Administration (FDA) awarded a firm fixed-price purchase order valued at $149,500.00 to Radix Biosolutions LLC, a for-profit limited liability company, for the procurement of an XMAP reagents-food allergen detection assay kit on a sole-source basis. The award supports the FDA's food safety inspection and sample analysis activities related to allergen testing and labeling requirements. Radix Biosolutions LLC has previously received...

The U.S. Food and Drug Administration (FDA) awarded a $19,460 firm-fixed-price purchase order contract to Crystal Chem Inc., a woman-owned small business, to provide ELISA test kits to support the detection of undeclared food allergens and gluten. This contract supports the regulatory enforcement of the Food Allergen Consumer Protection Act of 2004 (FALCPA) and the FDA's gluten-free regulation. Crystal Chem specializes in assays for the research community and has provided these goods as the prime contractor to the Department of Health and Human Services, with some prior awards set aside for small businesses. The contract has a period of performance through November 18, 2024.

Generated 9/24/24, 9:27 AM